Longeveron LLC - Class A (LGVN) Stock Price

0.542 ▲ +0.029 (+5.65%)
Open: 0.5441 Vol: 0 Day's range: 0.541 - 0.5519 Feb 09, 15:52 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LGVN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.55▼ 0.53▲ 0.53▲ 0.53▲ 0.55▼
MA10 0.53▲ 0.53▲ 0.53▲ 0.55▼ 0.57▼
MA20 0.53▲ 0.53▲ 0.53▲ 0.56▼ 0.65▼
MA50 0.54▲ 0.55▼ 0.56▼ 0.58▼ 1.03▼
MA100 0.56▼ 0.56▼ 0.56▼ 0.68▼ 1.55▼
MA200 0.56▼ 0.55▼ 0.56▼ 0.96▼ 18.88▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.004▲ 0.004▲ -0.003▼ 0.020▲
RSI 56.082▲ 53.068▲ 51.572▲ 46.328▼ 37.132▼
STOCH 89.896▲ 57.284     53.318     16.664▼ 33.515    
WILL %R -26.613     -25.320     -25.320     -72.428     -83.438▼
CCI 60.210     98.404     82.102     -38.426     -81.219    
Latest Filters Detected On LGVN
MA $LGVN Price Crossed Above MA(7) Set Alert
▲ GAP $LGVN Open Gap Up %5 Set Alert
▲ GAP $LGVN Open Gap Up %3 Set Alert
▲ GAP $LGVN Open Gap Up %2 Set Alert
CDL $LGVN Shooting Star Candlestick Pattern Detected Set Alert
CDL $LGVN Doji Candlestick Pattern Detected Set Alert
Longeveron LLC - Class A News
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
Thursday, February 05, 2026 06:15 AM
Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, supports and applauds ...
Longeveron Inc.
Friday, January 30, 2026 04:13 PM
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL ...
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Thursday, January 29, 2026 06:14 AM
Founder, Chief Science Officer and Executive Chairman, Longeveron The patent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue ...
LGVN historical stock data
date open high low close volume
09/02/26 0.5441 0.5519 0.541 0.542 97,240
06/02/26 0.52 0.531 0.51 0.513 81,000
05/02/26 0.557 0.557 0.501 0.511 306,339
04/02/26 0.53 0.55 0.525 0.54 168,800
03/02/26 0.543 0.565 0.531 0.553 117,700
02/02/26 0.56 0.5619 0.5212 0.536 245,894
30/01/26 0.572 0.60 0.547 0.56 158,700
29/01/26 0.6261 0.6261 0.5577 0.5798 205,505
28/01/26 0.60 0.60 0.5792 0.5941 110,605
27/01/26 0.621 0.621 0.558 0.5795 202,504
Quote Details
52wk Low:0.492
52wk High:1.92
Vol:0
Avg Vol(3m):4.8M
1Y Chng:-64.11%
1M Chng:+1.69%
Add to Watch List
More Information
Index US Composite
Market Cap. 14.72M